TLDR: Akasia 365mc Indonesia, under the leadership of Chief Executive Director Jane Dewi Tahir, has been awarded the Grand Prize for Best Brand in the AI Liposuction category at the 19th Korea Healthcare Industry Awards. The recognition highlights 365mc’s pioneering AI-powered liposuction technology and its successful expansion in Southeast Asia.
Seoul, South Korea – Akasia 365mc Indonesia, a prominent obesity-focused medical group, has achieved a significant milestone by securing the Grand Prize for Best Brand in the AI Liposuction category at the 19th Korea Healthcare Industry Awards. The prestigious ceremony took place on July 3 at the Riverside Hotel in Seoul, where Jane Dewi Tahir, Chief Executive Director of Akasia 365mc Indonesia, accepted the honor on behalf of the organization.
The award acknowledges 365mc’s exceptional leadership in the field of AI-powered liposuction technology and its remarkable global expansion, particularly across Southeast Asia. The medical group has demonstrated strong global competitiveness, notably with the establishment of overseas branches in Indonesia and Thailand, and recent expansion into Vietnam.
Since its entry into the Indonesian market in July 2023, 365mc has rapidly established a significant presence, opening three local clinics. Within a mere 16 months, the group has surpassed 30,000 RAMS bottle extractions, a proprietary procedure volume indicator, underscoring its operational efficiency and patient volume. Jane Dewi Tahir has been instrumental in this success, playing a pivotal role in localizing the Korean clinic’s advanced medical model through strategic collaborations with Indonesian healthcare corporations.
Commenting on the achievement, Tahir stated, “The reason 365mc’s advanced Korean medical technology could be replicated abroad lies in our AI-based, standardized treatment system. The scalability of this system will continue to accelerate our global growth.” This statement highlights the core of 365mc’s success: a robust, AI-driven approach that ensures consistent quality and allows for efficient replication across different markets.
Also Read:
- Perfect Corp.’s AI Skin Analysis Solution Honored with Newsweek AI Impact Award for Customer Experience
- Hyra Network Crowned ‘Technology Startup of the Year’ at Prestigious 2025 Globee® Awards
365mc’s commitment to artificial intelligence in healthcare dates back to 2017, when it began significant investments in AI-driven medical systems. A key innovation came in 2020 with the registration of a patent for an AI-powered cannula surgery diagnostic device. This cutting-edge device analyzes surgical motion data, significantly improving prediction accuracy and enabling more personalized postoperative care for patients. The integration of such advanced AI technologies has positioned 365mc at the forefront of the medical aesthetics industry, setting new standards for safety and efficacy in liposuction procedures.
